ArticleJournal for immunotherapy of cancer2024

Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.

Yongyuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.